(Q44164538)

English

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay

scientific article published on 22 March 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Enhanced detection of hepatitis B virus in Hong Kong blood donors after introduction of a more sensitive transcription-mediated amplification assay (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Hepatitis B virus

1 reference

based on heuristic

inferred from title

author name string

Wai-Chiu Tsoi

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Nico Lelie

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Che-Kit Lin

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

publication date

22 March 2013

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

10 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

2477-2488

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Epidemiological study of hepatitis B virus genotypes, core promoter and precore mutations of chronic hepatitis B infection in Hong Kong.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Hepatitis B virus blood screening: unfinished agendas

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Infectivity of human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus and risk of transmission by transfusion

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Assessing the impact of HBV NAT on window period reduction and residual risk

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Molecular characterization of occult hepatitis B virus in genotype E-infected subjects

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Hepatitis B virus transmission by blood transfusion during 4 years of individual-donation nucleic acid testing in South Africa: estimated and observed window period risk.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Statements from the Taormina expert meeting on occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Evidence of acute primary occult hepatitis B virus infection in an Italian repeat blood donor

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Refinement of a viral transmission risk model for blood donations in seroconversion window phase screened by nucleic acid testing in different pool sizes and repeat test algorithms.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

HBV NAT positive [corrected] blood donors in the early and late stages of HBV infection: analyses of the window period and kinetics of HBV DNA.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

A method for estimating hepatitis B virus incidence rates in volunteer blood donors. National Heart, Lung, and Blood Institute Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Superiority of minipool nucleic acid amplification technology for hepatitis B virus over chemiluminescence immunoassay for hepatitis B surface antigen screening

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Infectivity of blood products from donors with occult hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Characterization of occult hepatitis B virus strains in South African blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Characterization of occult hepatitis B virus from blood donors carrying genotype A2 or genotype D strains

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Occult hepatitis B infection in blood donors from South East Asia: molecular characterisation and potential mechanisms of occurrence.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Characterization of occult hepatitis B virus infection from blood donors in China

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Occult hepatitis B virus infection in Thai blood donors

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Nucleic acid testing to detect HBV infection in blood donors.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Anti-HBs positive occult hepatitis B virus carrier blood infectious in two transfusion recipients

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Lengths of hepatitis B viremia and antigenemia in blood donors: preliminary evidence of occult (hepatitis B surface antigen-negative) infection in the acute stage.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Transient occult hepatitis B virus infection in a blood donor with high viremia

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

18-year follow-up study of a prospective randomized trial of hepatitis B vaccinations without booster doses in children

1 reference

https://api.crossref.org/works/10.1111%2FTRF.12165

21 January 2018

Identifiers

10.1111/TRF.12165

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44164538&oldid=2107332103"